Literature DB >> 18334594

Accuracy of diagnostic tests for Cushing's syndrome: a systematic review and metaanalyses.

Mohamed B Elamin1, M Hassan Murad, Rebecca Mullan, Dana Erickson, Katherine Harris, Sarah Nadeem, Robert Ennis, Patricia J Erwin, Victor M Montori.   

Abstract

CONTEXT: The diagnosis of Cushing's syndrome (CS) requires the use of tests of unregulated hypercortisolism that have unclear accuracy.
OBJECTIVE: Our objective was to summarize evidence on the accuracy of common tests for diagnosing CS. DATA SOURCES: We searched electronic databases (MEDLINE, EMBASE, Web of Science, Scopus, and citation search for key articles) from 1975 through September 2007 and sought additional references from experts. STUDY SELECTION: Eligible studies reported on the accuracy of urinary free cortisol (UFC), dexamethasone suppression test (DST), and midnight cortisol assays vs. reference standard in patients suspected of CS. DATA EXTRACTION: Reviewers working in duplicate and independently extracted study characteristics and quality and data to estimate the likelihood ratio (LR) and the 95% confidence interval (CI) for each result. DATA SYNTHESIS: We found 27 eligible studies, with a high prevalence [794 (9.2%) of 8631 patients had CS] and severity of CS. The tests had similar accuracy: UFC (n = 14 studies; LR+ 10.6, CI 5.5-20.5; LR- 0.16, CI 0.08-0.33), salivary midnight cortisol (n = 4; LR+ 8.8, CI 3.5-21.8; LR- 0.07, CI 0-1.2), and the 1-mg overnight DST (n = 14; LR+ 16.4, CI 9.3-28.8; LR- 0.06, CI 0.03-0.14). Combined testing strategies (e.g. a positive result in both UFC and 1-mg overnight DST) had similar diagnostic accuracy (n = 3; LR+ 15.4, CI 0.7-358; LR- 0.11, CI 0.007-1.57).
CONCLUSIONS: Commonly used tests to diagnose CS appear highly accurate in referral practices with samples enriched with patients with CS. Their performance in usual clinical practice remains unclear.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18334594     DOI: 10.1210/jc.2008-0139

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  46 in total

1.  Biomarkers: Salivary cortisol or cortisone?

Authors:  Hershel Raff; James W Findling
Journal:  Nat Rev Endocrinol       Date:  2010-12       Impact factor: 43.330

Review 2.  Pros and cons of screening for occult Cushing syndrome.

Authors:  Antoine Tabarin; Paul Perez
Journal:  Nat Rev Endocrinol       Date:  2011-03-22       Impact factor: 43.330

3.  The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.

Authors:  Lynnette K Nieman; Beverly M K Biller; James W Findling; John Newell-Price; Martin O Savage; Paul M Stewart; Victor M Montori
Journal:  J Clin Endocrinol Metab       Date:  2008-03-11       Impact factor: 5.958

4.  Hair cortisol in the evaluation of Cushing syndrome.

Authors:  Aaron Hodes; Maya B Lodish; Amit Tirosh; Jerrold Meyer; Elena Belyavskaya; Charalampos Lyssikatos; Kendra Rosenberg; Andrew Demidowich; Jeremy Swan; Nichole Jonas; Constantine A Stratakis; Mihail Zilbermint
Journal:  Endocrine       Date:  2017-02-13       Impact factor: 3.633

Review 5.  Cushing's syndrome: update on signs, symptoms and biochemical screening.

Authors:  Lynnette K Nieman
Journal:  Eur J Endocrinol       Date:  2015-07-08       Impact factor: 6.664

Review 6.  Cushing's syndrome: why is diagnosis so difficult?

Authors:  David C Aron
Journal:  Rev Endocr Metab Disord       Date:  2010-06       Impact factor: 6.514

7.  Power spectrum scale invariance quantifies limbic dysregulation in trait anxious adults using fMRI: adapting methods optimized for characterizing autonomic dysregulation to neural dynamic time series.

Authors:  Denis Tolkunov; Denis Rubin; Lr Mujica-Parodi
Journal:  Neuroimage       Date:  2009-12-16       Impact factor: 6.556

8.  [Unexplained weight gain in a 41-year-old woman].

Authors:  I A Harsch; E G Hahn
Journal:  Internist (Berl)       Date:  2010-03       Impact factor: 0.743

9.  Specificity of screening tests for Cushing's syndrome in an overweight and obese population.

Authors:  Smita K Baid; Domenica Rubino; Ninet Sinaii; Sheila Ramsey; Arthur Frank; Lynnette K Nieman
Journal:  J Clin Endocrinol Metab       Date:  2009-07-14       Impact factor: 5.958

10.  Bone turnover in patients with endogenous Cushing's syndrome before and after successful treatment.

Authors:  A Szappanos; J Toke; D Lippai; A Patócs; P Igaz; N Szücs; L Füto; E Gláz; K Rácz; M Tóth
Journal:  Osteoporos Int       Date:  2009-06-10       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.